RESEARCH AGREEMENT BETWEEN FIDELITY MANAGEMENT & RESEARCH (FAR EAST), INC. AND FIDELITY INVESTMENTS JAPAN LIMITED AGREEMENT made this 1st day of January, 2000 by and between Fidelity Management & Research (Far East), Inc., a Massachusetts corporation...Research Agreement • September 27th, 2000 • Fidelity Advisor Series Vii • Massachusetts
RESEARCH AGREEMENT Between FIDELITY MANAGEMENT & RESEARCH (Far East), INC. and FIDELITY INVESTMENTS JAPAN LIMITEDResearch Agreement • July 30th, 2001 • Fidelity Advisor Series I • Massachusetts
AGREEMENT made this 19th day of April, 2001, by and between Fidelity Management & Research (Far East), Inc., a Massachusetts corporation (the "Sub-Advisor"); and Fidelity Investments Japan Limited, a Japanese corporation (the "Japan Sub-Advisor").
Exhibit 10.1 RESEARCH AGREEMENT November 27, 2012 This Research Agreement (the "Agreement") is made AMONG: GLOBAL STEVIA CORP. a Nevada corporation, with its principal offices at No 47, Alley 86, Chua Ha Street, Cau Giay District, Hanoi city, Vietnam....Research Agreement • December 3rd, 2012 • Global Stevia Corp. • Retail-food stores
AMENDED AND RESTATED MASTER INTERNATIONAL RESEARCH AGREEMENT between FIDELITY INTERNATIONAL INVESTMENT ADVISORS and FIDELITY MANAGEMENT & RESEARCH COMPANYResearch Agreement • March 2nd, 2009 • Fidelity Contrafund • Massachusetts
AGREEMENT made this 1st day of August 2007 by and between Fidelity Management & Research Company, a Massachusetts corporation with principal offices at 82 Devonshire Street, Boston, Massachusetts (hereinafter called the "Advisor") and Fidelity International Investment Advisors, a Bermuda company with principal offices at Pembroke Hall, Pembroke, Bermuda (hereinafter called the "Sub-Advisor").
AMENDED AND RESTATED MASTER INTERNATIONAL FIXED-INCOME RESEARCH AGREEMENT between FIDELITY INTERNATIONAL INVESTMENT ADVISORS and FIDELITY INVESTMENTS MONEY MANAGEMENT, INC.Research Agreement • January 13th, 2010 • Fidelity Union Street Trust Ii • Massachusetts
AGREEMENT made this 1st day of August, 2007 by and between Fidelity Investments Money Management, Inc., a New Hampshire corporation with principal offices at Contra Way, P.O. Box 9600, Merrimack, New Hampshire (hereinafter called the "U.S. Sub-Advisor") and Fidelity International Investment Advisors, a Bermuda company with principal offices at Pembroke Hall, Pembroke, Bermuda (hereinafter called the "Foreign Sub-Advisor").
RESEARCH AGREEMENT Between FIDELITY MANAGEMENT & RESEARCH (Far East), INC. and FIDELITY INVESTMENTS JAPAN LIMITED AGREEMENT made this 1st day of January, 2000, by and between Fidelity Management & Research (Far East), Inc., a Massachusetts corporation...Research Agreement • December 1st, 2000 • Fidelity Charles Street Trust • Massachusetts
EXHIBIT 10.26 AMENDMENT NO. 1 OF RESEARCH AGREEMENT The Agreement amendments stated herein are made by and between Antigenics, L.L.C., hereinafter referred to as Sponsor and the University of Connecticut Health Center, hereinafter referred to as UCHC....Research Agreement • March 31st, 2005 • Antigenics Inc /De/ • Biological products, (no disgnostic substances)
EXHIBIT 10.9 RESEARCH AGREEMENT ------------------ This Research Agreement (the "Agreement") is made as of this 18th day of November, 1999 by and between YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, 46 Jabotinsky Street,...Research Agreement • July 24th, 2000 • Keryx Biophamaeuticals Inc • Services-commercial physical & biological research
RESEARCH AGREEMENT BETWEEN FIDELITY MANAGEMENT & RESEARCH (FAR EAST), INC. AND FIDELITY INVESTMENTS JAPAN LIMITED AGREEMENT made this 1st day of January, 2000 by and between Fidelity Management & Research (Far East), Inc., a Massachusetts corporation...Research Agreement • June 28th, 2000 • Fidelity Advisor Series Ii • Massachusetts
Exhibit 10.10 RESEARCH AGREEMENT Research Agreement between Cold Spring Harbor Laboratory, hereinafter referred to as "CSHL," and Tularik Inc., hereinafter referred to as "Sponsor". This Agreement is entered into as of October 3, 1997 and will be...Research Agreement • December 17th, 1999 • Tularik Inc • Services-commercial physical & biological research • New York
RESEARCH AGREEMENT AMONG CALVERT SOCIAL INVESTMENT FUND CALVERT WORLD VALUES FUND, INC. CALVERT IMPACT FUND, INC. AND JEAN-LUC PARKResearch Agreement • January 31st, 2008 • Calvert Social Investment Fund • Maryland
RESEARCH AGREEMENT, made this 4th day of December, 2007, by and, separately as to itself, each of between Calvert Social Investment Fund, a Massachusetts business trust, Calvert World Values Fund, Inc., a Maryland corporation, Calvert Impact Fund, a Maryland corporation (each, a "Fund"), and Jean-Luc Park ("Park").
Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. INDUSTRY-UNIVERSITY COOPERATIVE RESEARCH AGREEMENTResearch Agreement • April 20th, 2006 • Innovive Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
THIS AGREEMENT, effective this 16th day of March 2005, by and between The Pennsylvania State University College of Medicine and The Milton S. Hershey Medical Center (hereinafter referred to collectively as "University") and INNOVIVE Pharmaceuticals, Inc., (hereinafter referred to as "Contractor").
RESEARCH AGREEMENT NO. BY AND BETWEEN SURGIVISION, INC. AND THE UNIVERSITY OF UTAHResearch Agreement • December 28th, 2011 • Mri Interventions, Inc. • Surgical & medical instruments & apparatus • Utah
This Research Agreement (“Agreement”) is entered into and effective as of , by and between Surgi Vision, Inc, a Delaware corporation having a principal place of business at 200 N Cobb Parkway, Suite 140, Marietta, Georgia 30062 (“Sponsor”) and the University of Utah, a body politic and corporate of the State of Utah (“University”).
Gerald Commissiong July 21, 2010 Amarantus Therapeutics, Inc. Sunnyvale, CA 94085-2934 Dear Mr. Commissiong:Research Agreement • June 3rd, 2011 • Amarantus BioSciences, Inc. • Retail-retail stores, nec • California
Pursuant to our recent conversation in which we discussed a Sponsored Research Agreement ("Agreement") to more effectively pursue our mutual research interests, the following terms are set forth below and are effective July 22, 2010.
RESEARCH AGREEMENTResearch Agreement • October 31st, 2014 • Enumeral Biomedical Holdings, Inc. • Pharmaceutical preparations • New Jersey
This Research Agreement (the “Agreement”), effective as of June 18th, 2012 (“Effective Date”), is entered into by and between Enumeral Biomedical Corp., a Delaware corporation with an address at 1450 Broadway, 24th Floor, New York, New York 10018 ("ENUMERAL"), and sanofi-aventis U.S. Inc., having an address at 1041 Route 202-206, P.O. Box 6800, Bridgewater, NJ 08807-0800 (hereinafter referred to as “SANOFI US”). Each of ENUMERAL and SANOFI US are referred to herein as a “Party” or collectively as the “Parties”.
EXHIBIT D(16) RESEARCH AGREEMENT BETWEEN FIDELITY MANAGEMENT & RESEARCH (FAR EAST), INC. AND FIDELITY INVESTMENTS JAPAN LIMITED AGREEMENT made this 1st day of January, 2000, by and between Fidelity Management & Research (Far East), Inc., a...Research Agreement • June 28th, 2000 • Fidelity Fixed Income Trust • Massachusetts
Exhibit d(12) RESEARCH AGREEMENT BETWEEN FIDELITY MANAGEMENT & RESEARCH (FAR EAST), INC. AND FIDELITY INVESTMENTS JAPAN LIMITED AGREEMENT made this 1st day of January, 2000, by and between Fidelity Management & Research (Far East), Inc., a...Research Agreement • September 26th, 2000 • Fidelity Puritan Trust • Massachusetts
RECITALSResearch Agreement • March 3rd, 2005 • Ivivi Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New Jersey
RESEARCH AGREEMENT THIS RESEARCH AGREEMENT effective as of the 1st day of September, 2000 by and between IXION BIOTECHNOLOGY, INC., a small business with offices located at 137009 Progress Blvd., Box 13, (hereinafter referred to as "SPONSOR") and the...Research Agreement • November 14th, 2000 • Ixion Biotechnology Inc • Pharmaceutical preparations • Florida
RESEARCH AGREEMENTResearch Agreement • July 11th, 2016 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS RESEARCH AGREEMENT (this “Agreement”), dated as of September 15th, 2015 (the “Effective Date”), between Fortress Biotech, Inc. (f/k/a Coronado Biosciences, Inc.), a Delaware Corporation (the “Company”) having an address 3 Columbus Circle, 15th Floor, New York, NY 10019, and NeuPharma, Inc., a Delaware corporation (“NeuPharma”) having an address of 1175 Chess Drive, Ste 206, Foster City, CA 94404.
RESEARCH AGREEMENT NO. STI-50121Research Agreement • November 29th, 2010 • Shrink Nanotechnologies, Inc. • Semiconductors & related devices • California
This agreement (“Agreement”) is entered into this 14th day of September 2010, by and between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, on behalf of its Irvine campus ("University") and Shrink Technologies, Inc., a California corporation, with offices at 2038 Corte Del Nogal, Suite 110, Carlsbad, CA 92011 ("Sponsor"). University and Sponsor shall be collectively referred to as the Parties and agree as follows:
RESEARCH AGREEMENTResearch Agreement • June 23rd, 2008 • International Energy, Inc. • Services-business services, nec • California
THIS AGREEMENT, effective as of September 17, 2007 (“Effective Date”), is made and entered into by and between INTERNATIONAL ENERY CORPORATION, having an address at Suite 216 - 1628 West 1st Avenue, Vancouver, British Columbia, V6J 1G1, Canada ("Sponsor") and THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California Corporation, acting through its Industry Alliances Office at the University of California, Berkeley, 2150 Shattuck Avenue, Suite 950, Berkeley, CA 94704-6701 (“California”).
ContractResearch Agreement • June 27th, 2014 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • New York
[Pursuant to 17 C.F.R. 240.24b-2, confidential information has been omitted in places marked “[…***…]” and has been filed separately with the Securities and Exchange Commission pursuant to a Confidential Treatment Application.]
RESEARCH AGREEMENTResearch Agreement • May 8th, 2007 • Diversa Corp • Services-commercial physical & biological research • Florida
THIS AGREEMENT effective this 20 day of December, 2004 by and between BC INTERNATIONAL CORPORATION, with offices located at 980 Washington Street, Suite 122, Dedham, MA 02026, (hereinafter referred to as “Sponsor”) and the UNIVERSITY OF FLORIDA BOARD OF TRUSTEES, an educational institution of the State of Florida (“University”).
RESEARCH AGREEMENTResearch Agreement • March 26th, 2010 • Tengion Inc • Biological products, (no disgnostic substances) • North Carolina
THIS RESEARCH AGREEMENT (the “Agreement”) is made effective as of January 1, 2006 (the “Effective Date”), by and between TENGION, INC., a corporation organized under the laws of the State of Delaware, whose offices are located at 2200 Renaissance Boulevard, Suite 150, King of Prussia, Pennsylvania 19406 (hereinafter “Tengion”), and WAKE FOREST UNIVERSITY HEALTH SCIENCES, an educational institution organized under the laws of the State of North Carolina, whose offices are located on Medical Center Boulevard, Winston-Salem, North Carolina 27157 (“WFUHS” and, together with Tengion, the “Parties” or individually a “Party”).
ContractResearch Agreement • October 3rd, 2014 • Intermolecular Inc • Semiconductors & related devices
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
RESEARCH AGREEMENTResearch Agreement • March 15th, 2012 • Ceres Ventures, Inc. • Services-specialty outpatient facilities, nec • California
This Research Agreement (“Agreement”) is entered on this 9th day of December, 2010 into by and between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California Constitutional corporation, on behalf of its Santa Barbara campus, hereinafter called “University,” and, NASCENT WATER TECHNOLOGIES, INC., a California corporation, and wholly-owned subsidiary of AcquaeBlu Corporation, a Delaware Corporation, having a principal place of business at 430 Park Avenue, Suite 702, New York, NY 10022, hereinafter called “Sponsor.”
RESEARCH AGREEMENTResearch Agreement • April 14th, 2015 • MultiCell Technologies, Inc. • Pharmaceutical preparations • California
This RESEARCH AGREEMENT (the “Agreement”), effective as of March 10, 2015 (the “Effective Date”), is made by and between Oxis Biotech, Inc., a Delaware corporation, having a place of business at 1407 North Beverly Drive, Beverly Hills, CA 90210 (“OXIS”) and MultiCell Immunotherapeutics, Inc., a Delaware corporation, having a place of business at 68 Cumberland Street, Suite 301, Woonsocket, RI 02895 (hereinafter “MCIT”).
RESEARCH AGREEMENT BETWEEN FIDELITY MANAGEMENT & RESEARCH (FAR EAST), INC. AND FIDELITY INVESTMENTS JAPAN LIMITED AGREEMENT made this 1st day of January, 2000 by and between Fidelity Management & Research (Far East), Inc., a Massachusetts corporation...Research Agreement • June 28th, 2000 • Fidelity Advisor Series Ii • Massachusetts
RESEARCH AGREEMENT A19-3095Research Agreement • September 30th, 2019 • Cabaletta Bio, Inc. • Biological products, (no disgnostic substances) • California
This Research Agreement (“Agreement”) is entered into this 31st day of October, 2018 (“Effective Date”), by and between Cabaletta Bio, Inc., a corporation with its place of business at 501 Northwick Lane, Villanova, PA 19085 (“Sponsor”) and The Regents of the University of California, a public educational institution, on behalf of its Davis campus (“University”), hereinafter the “Parties.”
RESEARCH AGREEMENTResearch Agreement • February 23rd, 2001 • Seattle Genetics Inc /Wa • Services-commercial physical & biological research • California
THIS RESEARCH AGREEMENT dated as of June 8, 1993 (the "Agreement"), is entered into between IXSYS, INC., a Delaware corporation ("Ixsys"), having a place of business located at 3550 General Atomics Court, Suite L-103, San Diego, California 92121, and BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation ("Bristol-Myers"), having a place of business located at Route 206 and Province Line Road, Princeton, New Jersey 08543-4000.
1. 2 1.2 "AURORA PATENT" means the rights granted by any governmental authority under a Patent which covers a Product or a method of use, apparatus, material or manufacture useful in the discovery, development, manufacture, use or sale of a Product,...Research Agreement • May 29th, 1997 • Aurora Biosciences Corp • Services-commercial physical & biological research • California
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. RESEARCH AGREEMENTResearch Agreement • October 4th, 2013 • Karyopharm Therapeutics Inc. • Pharmaceutical preparations • New York
This Research Agreement (this “Agreement”) is made as of the 18th day of July, 2011 (the “Effective Date”) by and between The Multiple Myeloma Research Foundation, Inc., a Connecticut non-stock corporation, with its principal place of business at 383 Main Avenue, 5th floor, Norwalk, CT 06851 (“MMRF”) and Karyopharm Therapeutics Inc., a Delaware corporation, with its principal place of business at 2 Mercer Road, Natick, MA 01760 (“Company”). MMRF and Company are sometimes hereinafter referred to individually as the “Party” and together as the “Parties”.
RESEARCH AGREEMENT BETWEEN FIDELITY MANAGEMENT & RESEARCH (FAR EAST), INC. AND FIDELITY INVESTMENTS JAPAN LIMITED AGREEMENT made this 1st day of January, 2000, by and between Fidelity Management & Research (Far East), Inc., a Massachusetts corporation...Research Agreement • April 28th, 2000 • Fidelity Union Street Trust • Massachusetts
RESEARCH AGREEMENT BETWEEN FIDELITY MANAGEMENT & RESEARCH (FAR EAST), INC. AND FIDELITY INVESTMENTS JAPAN LIMITED AGREEMENT made this 1st day of January, 2000, by and between Fidelity Management & Research (Far East), Inc., a Massachusetts corporation (the "Sub-Advisor"); and Fidelity Investments Japan Limited, a Japanese corporation (the "Japan Sub-Advisor"). WHEREAS, Fidelity Management & Research Company, a Massachusetts corporation (the "Advisor"), has entered into a Management Contract (the "Management Contract") with Fidelity Union Street Trust, a Massachusetts business trust which may issue one or more series of shares of beneficial interest (the "Trust"), on behalf of Fidelity Export and Multinational Fund (the "Portfolio"), pursuant to which the Advisor acts as investment advisor to the Portfolio; and WHEREAS, the Sub-Advisor has entered into a Sub-Advisory Agreement (the "Sub-Advisory Agreement") with the Advisor, pursuant to which the Sub-Advisor, directly or through certain
RECITALSResearch Agreement • September 10th, 2004 • Arbios Systems Inc • Surgical & medical instruments & apparatus • California